1.
Petrelli F, Caraffa A, Scuri S, Grappasonni I, Magrini E, Cocchini A. The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices. Acta Biomed [Internet]. 2019 May 23 [cited 2024 Jul. 18];90(2):288-99. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/8340